Used primarily as an intermediate in pharmaceutical synthesis, especially in the preparation of kinase inhibitors for cancer treatment. Its boronate ester group enables Suzuki-Miyaura cross-coupling reactions, allowing efficient formation of carbon-carbon bonds in complex molecules. Commonly employed in the development of targeted therapies, including those for leukemia and solid tumors. Also utilized in research settings for the synthesis of novel bioactive compounds and in medicinal chemistry for lead optimization.